Jennifer McQuade

22PUBLICATIONS
235CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|Apr 22, 2024
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.

Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett

|Aug 14, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update.

Rahul Seth, Sanjiv S Agarwala, Hans Messersmith

|Jun 12, 2023
Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation.

Hannah Savage, Sumedha Pareek, Jonghae Lee

|May 08, 2023
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.

Javier Leo, Eleonora Dondossola, Kaitlin J Basham

|Mar 30, 2023
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.

Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett

Pageof 4

Frequent Collaborators

15 joint publications

Michael T Tetzlaff

9 joint publications

Jennifer A Wargo

9 joint publications

Hussein A Tawbi

9 joint publications

Sapna Patel